Royal Bank of Canada
CMRA

Royal Bank of Canada’s Comera Life Sciences Holdings, Inc. Common Stock CMRA Stock Holding History

Royal Bank of Canada’s Portfolio CMRA Stock Details CMRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1
Closed – – 7974
2022
Q3 		$0 Buy
+1
New +$2 ﹤0.01% 8069

Other funds holding CMRA

LSAG
Lake Street Advisors Group Portsmouth, New Hampshire $2.17B AUM 16.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.66% 1-Year Est. Return

Royal Bank of Canada's CMRA Position: Q4 2022 in Review

Royal Bank of Canada sold out of Comera Life Sciences Holdings, Inc. Common Stock (CMRA) in Q4 2022, closing a stake of 1 share.

Royal Bank of Canada first reported a position in CMRA in Q3 2022 and held it in 1 quarter. The position peaked at $0 in Q3 2022. 12 funds tracked by Wall St. Rank hold CMRA as of Q4 2022.

  • Royal Bank of Canada reported no remaining Comera Life Sciences Holdings, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Royal Bank of Canada sold 1 Comera Life Sciences Holdings, Inc. Common Stock share in Q4 2022.
  • Royal Bank of Canada first reported a position in Comera Life Sciences Holdings, Inc. Common Stock in Q3 2022 and held it in 1 quarter.
  • Royal Bank of Canada's Comera Life Sciences Holdings, Inc. Common Stock position peaked at $0 in Q3 2022.
  • 12 funds tracked by Wall St. Rank held Comera Life Sciences Holdings, Inc. Common Stock as of Q4 2022.

Based on Royal Bank of Canada's 13F filing for Q4 2022, filed 14 Feb 2023.